Hsa‐mir‐153 was found to be down‐regulated in NSCLC tissues and cell lines; it inhibits migration and invasion of NSCLC by targeting ADAM1919 and protein kinase B (AKT) 20. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.